Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis
- 30 September 2008
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 213 (1), 18-27
- https://doi.org/10.1016/j.expneurol.2008.04.022
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Neurological deterioration in late infantile neuronal ceroid lipofuscinosisNeurology, 2007
- Newborn screening in North AmericaJournal of Inherited Metabolic Disease, 2007
- Recent advances in newborn screeningJournal of Inherited Metabolic Disease, 2007
- New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapyHuman Genetics, 2006
- Newborn screening for lysosomal storage disordersMolecular Genetics and Metabolism, 2006
- CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosisMolecular Therapy, 2006
- Neurological Manifestations in Lysosomal Storage Disorders - From Pathology to First Therapeutic PossibilitiesNeuropediatrics, 2005
- Screening for lysosomal storage disorders—A clinical perspectiveJournal of Inherited Metabolic Disease, 2005
- AAV-Mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophyMolecular Therapy, 2005
- Administration of a Replication-Deficient Adeno-Associated Virus Gene Transfer Vector Expressing the HumanCLN2cDNA to the Brain of Children with Late Infantile Neuronal Ceroid LipofuscinosisHuman Gene Therapy, 2004